chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 95.0
Sex: F
Vaccine: COVID19
Symptoms: Nasal discharge discolouration, Rhinorrhoea
Clinical narrative: now its turning slightly yellowish color; heavy, thick post-nasal drainage; This spontaneous case was reported by a consumer and describes the occurrence of RHINORRHOEA (heavy, thick post-nasal drainage) and NASAL DISCHARGE DISCOLOURATION (now its turning slightly yellowish color) in a 95-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 023A20A and 042L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 28-May-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced RHINORRHOEA (heavy, thick post-nasal drainage). On an unknown date, the patient experienced NASAL DISCHARGE DISCOLOURATION (now its turning slightly yellowish color). The patient was treated with IPRATROPIUM ongoing since an unknown date at an unspecified dose and frequency and FLUTICASONE PROPIONATE (FLONASE ALLERGY RELIEF) (nasal) ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, RHINORRHOEA (heavy, thick post-nasal drainage) and NASAL DISCHARGE DISCOLOURATION (now its turning slightly yellowish color) outcome was unknown.            Action taken with mRNA-1273 in response to the events was not applicable  Concomitant product use was not provided.
Sex: U
Vaccine: COVID19
Symptoms: Peripheral swelling
Clinical narrative: Swelling in the arm; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Swelling in the arm) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 28-May-2021, the patient experienced PERIPHERAL SWELLING (Swelling in the arm). At the time of the report, PERIPHERAL SWELLING (Swelling in the arm) outcome was unknown.      Action taken with mRNA-1273 in response to the events was not applicable  No concomitant medications provided No treatment medications provided
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Received the second shot 7 weeks after the first shot; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received the second shot 7 weeks after the first shot) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 28-May-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received the second shot 7 weeks after the first shot). On 28-May-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received the second shot 7 weeks after the first shot) had resolved.       Action taken with mRNA-1273 in response to the event was not applicable.  No concomitant medications were reported. Treatment information was not provided.   Reporter did not allow further contact
Sex: U
Vaccine: COVID19
Symptoms: Diarrhoea
Clinical narrative: Diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     Concurrent medical conditions included Ulcerative colitis.    On 29-May-2021 at 12:40 PM, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-May-2021, the patient experienced DIARRHOEA (Diarrhea). At the time of the report, DIARRHOEA (Diarrhea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient reported that is on an injections for ulcerative colitis. Second dose of vaccine was taken on 29-MAY-2021 at 12:40 and have started with diarrhea a few minutes ago.
Sex: U
Vaccine: COVID19
Symptoms: Cough
Clinical narrative: Harsh cough; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of COUGH (Harsh cough) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 27-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-May-2021, the patient experienced COUGH (Harsh cough). At the time of the report, COUGH (Harsh cough) outcome was unknown.            No Medical history, Lab data, Concomitant medications and treatment medications are reported. Action taken with mRNA-1273 in response to the events were not applicable.
Sex: U
Vaccine: COVID19
Symptoms: Pruritus, Rash
Clinical narrative: Arms itched again after second shot; Rashes on both arms; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Arms itched again after second shot) and RASH (Rashes on both arms) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PRURITUS (Arms itched again after second shot) and RASH (Rashes on both arms). At the time of the report, PRURITUS (Arms itched again after second shot) and RASH (Rashes on both arms) outcome was unknown.            no treatment information was reported no concomitant medication were reported     Reporter did not allow further contact
Sex: U
Vaccine: COVID19
Symptoms: Chest pain
Clinical narrative: pain in chest; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of CHEST PAIN (pain in chest) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced CHEST PAIN (pain in chest). At the time of the report, CHEST PAIN (pain in chest) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       no concomitant medications are provided. treatment to the events not reported.
Sex: U
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: Right side pain that began immediately after my second vaccination; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Right side pain that began immediately after my second vaccination) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's medical history not reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced MYALGIA (Right side pain that began immediately after my second vaccination). At the time of the report, MYALGIA (Right side pain that began immediately after my second vaccination) outcome was unknown.            no concomitant medication reported.
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: Diarrhoea, Vomiting
Clinical narrative: felt "violently seek"; diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of VOMITING (felt "violently seek") and DIARRHOEA (diarrhea) in a 48-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.   On 20-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-May-2021, the patient experienced VOMITING (felt "violently seek") and DIARRHOEA (diarrhea). At the time of the report, VOMITING (felt "violently seek") and DIARRHOEA (diarrhea) outcome was unknown.            No concomitant medications were provided No treatment medications were provided   Reporter did not allow further contact
Sex: M
Vaccine: COVID19
Symptoms: Headache, Pyrexia
Clinical narrative: feeling hard headache; Fever; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (feeling hard headache) and PYREXIA (Fever) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HEADACHE (feeling hard headache) and PYREXIA (Fever). At the time of the report, HEADACHE (feeling hard headache) and PYREXIA (Fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.  No treatment information was provided.    Reporter did not allow further contact
Sex: U
Vaccine: COVID19
Symptoms: Feeling abnormal, Pain in extremity
Clinical narrative: Started feeling a bod after the 2nd dose; Bad pain on the right leg after the 2nd dose; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Bad pain on the right leg after the 2nd dose) and FEELING ABNORMAL (Started feeling a bod after the 2nd dose) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.    On 29-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-May-2021, the patient experienced PAIN IN EXTREMITY (Bad pain on the right leg after the 2nd dose). On 30-May-2021, the patient experienced FEELING ABNORMAL (Started feeling a bod after the 2nd dose). The patient was treated with PARACETAMOL (TYLENOL) on 29-May-2021 at a dose of 650 mg. On 29-May-2021, PAIN IN EXTREMITY (Bad pain on the right leg after the 2nd dose) had resolved. At the time of the report, FEELING ABNORMAL (Started feeling a bod after the 2nd dose) outcome was unknown.            Concomitant drug was not reported.  It was reported that patient was feeling bad and needed help.
Sex: U
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: fever; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PYREXIA (fever). At the time of the report, PYREXIA (fever) outcome was unknown.            No concomitant medications provided. No treatment information provided.
Sex: F
Vaccine: COVID19
Symptoms: Breast pain, Discomfort, Vaccination site pain
Clinical narrative: I started to feel something uncomfortable; sore arm; soreness breast; This spontaneous case was reported by a consumer and describes the occurrence of DISCOMFORT (I started to feel something uncomfortable), VACCINATION SITE PAIN (sore arm) and BREAST PAIN (soreness breast) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Mammogram (Negative) on 22-Dec-2020.    In March 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DISCOMFORT (I started to feel something uncomfortable), VACCINATION SITE PAIN (sore arm) and BREAST PAIN (soreness breast). At the time of the report, DISCOMFORT (I started to feel something uncomfortable), VACCINATION SITE PAIN (sore arm) and BREAST PAIN (soreness breast) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitants were reported. No treatment was reported.
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Inappropriate schedule of product administration, SARS-CoV-2 test
Clinical narrative: Inappropriate schedule of product administration; patient tested positive for covid19; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (patient tested positive for covid19) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of product administration) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 31-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Jan-2021, the patient experienced COVID-19 (patient tested positive for covid19). On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of product administration). At the time of the report, COVID-19 (patient tested positive for covid19) outcome was unknown and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of product administration) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 10-Feb-2021, SARS-CoV-2 test: positive (Positive) tested positive for covid19.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was reported. No treatment was reported. Patient wants to know if she can take the second dose of the vaccine.
Sex: U
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: Patient has not received their 2nd dose Patient is at day 53; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Patient has not received their 2nd dose Patient is at day 53) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Apr-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (Patient has not received their 2nd dose Patient is at day 53). On 05-Apr-2021, PRODUCT DOSE OMISSION ISSUE (Patient has not received their 2nd dose Patient is at day 53) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product information was not provided. Treatment information was not provided.
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, COVID-19, Chills, Exposure during pregnancy, High risk pregnancy
Clinical narrative: face got swollen; didn't have taste; fever; body aches; chills; high-risk pregnancy; diagnosed with COVID-19; Vaccine exposure during pregnancy; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy), HIGH RISK PREGNANCY (high-risk pregnancy), COVID-19 (diagnosed with COVID-19), SWELLING FACE (face got swollen) and AGEUSIA (didn't have taste) in a 20-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 009C21A and 037A21B) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included PROMETHAZINE HCL for an unknown indication.   On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. The patient's last menstrual period was on 26-Mar-2021 and the estimated date of delivery was 31-Dec-2021. On 14-Apr-2021, the patient experienced EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy). On 28-May-2021, the patient experienced COVID-19 (diagnosed with COVID-19). On an unknown date, the patient experienced HIGH RISK PREGNANCY (high-risk pregnancy), SWELLING FACE (face got swollen), AGEUSIA (didn't have taste), PYREXIA (fever), MYALGIA (body aches) and CHILLS (chills). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  second week of the pregnancy.  The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. On 14-Apr-2021, EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) had resolved. At the time of the report, HIGH RISK PREGNANCY (high-risk pregnancy), COVID-19 (diagnosed with COVID-19), SWELLING FACE (face got swollen), AGEUSIA (didn't have taste), PYREXIA (fever), MYALGIA (body aches) and CHILLS (chills) outcome was unknown.
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Pyrexia, Swelling face
Clinical narrative: face got swollen; didn't have taste; fever; body aches; chills; high-risk pregnancy; diagnosed with COVID-19; Vaccine exposure during pregnancy; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy), HIGH RISK PREGNANCY (high-risk pregnancy), COVID-19 (diagnosed with COVID-19), SWELLING FACE (face got swollen) and AGEUSIA (didn't have taste) in a 20-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 009C21A and 037A21B) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included PROMETHAZINE HCL for an unknown indication.   On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. The patient's last menstrual period was on 26-Mar-2021 and the estimated date of delivery was 31-Dec-2021. On 14-Apr-2021, the patient experienced EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy). On 28-May-2021, the patient experienced COVID-19 (diagnosed with COVID-19). On an unknown date, the patient experienced HIGH RISK PREGNANCY (high-risk pregnancy), SWELLING FACE (face got swollen), AGEUSIA (didn't have taste), PYREXIA (fever), MYALGIA (body aches) and CHILLS (chills). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  second week of the pregnancy.  The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. On 14-Apr-2021, EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) had resolved. At the time of the report, HIGH RISK PREGNANCY (high-risk pregnancy), COVID-19 (diagnosed with COVID-19), SWELLING FACE (face got swollen), AGEUSIA (didn't have taste), PYREXIA (fever), MYALGIA (body aches) and CHILLS (chills) outcome was unknown.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Erythema, Feeling abnormal, Pruritus, Rash, Rash macular
Clinical narrative: Redness in other arm; Feel the bumps of the rash; Feels like I've been bit by a bunch of insects; Itching a lot; This morning I had a rash,started in the arm of the injection,started off in one spotfeel the bumps; This spontaneous case was reported by a patient and describes the occurrence of ERYTHEMA (Redness in other arm), RASH MACULAR (Feel the bumps of the rash), FEELING ABNORMAL (Feels like I've been bit by a bunch of insects), PRURITUS (Itching a lot) and RASH (This morning I had a rash,started in the arm of the injection,started off in one spotfeel the bumps) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026B21A) for COVID-19 vaccination.     Concomitant products included MILK THISTLE [SILYBUM MARIANUM], OMEPRAZOLE, ZOLPIDEM TARTRATE (AMBIEN), LEVOTHYROXINE SODIUM, BENAZEPRIL, AMLODIPINE, METOPROLOL, METFORMIN, VENLAFAXINE HYDROCHLORIDE (EFFEXOR), MONTELUKAST, HYDROCHLOROTHIAZIDE, FOLIC ACID, MULTIVITAMIN [VITAMINS NOS], VITAMIN B12 NOS and FISH OIL for an unknown indication.    On 19-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-May-2021, the patient experienced ERYTHEMA (Redness in other arm), RASH MACULAR (Feel the bumps of the rash), FEELING ABNORMAL (Feels like I've been bit by a bunch of insects), PRURITUS (Itching a lot) and RASH (This morning I had a rash,started in the arm of the injection,started off in one spotfeel the bumps). The patient was treated with HYDROCORTISONE (topical) at an unspecified dose and frequency. At the time of the report, ERYTHEMA (Redness in other arm), RASH MACULAR (Feel the bumps of the rash), FEELING ABNORMAL (Feels like I've been bit by a bunch of insects), PRURITUS (Itching a lot) and RASH (This morning I had a rash,started in the arm of the injection,started off in one spotfeel the bumps) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. .
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, COVID-19, Chills, Myalgia, Pyrexia
Clinical narrative: tested positive for COVID; fever 102; chills; body aches; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of COVID-19 (tested positive for COVID), PYREXIA (fever 102), CHILLS (chills) and MYALGIA (body aches) in a 55-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Apr-2021, the patient experienced COVID-19 (tested positive for COVID), PYREXIA (fever 102), CHILLS (chills) and MYALGIA (body aches). At the time of the report, COVID-19 (tested positive for COVID), PYREXIA (fever 102), CHILLS (chills) and MYALGIA (body aches) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 12-Apr-2021, Body temperature: 102 (High) 102. On 12-Apr-2021, SARS-CoV-2 test: positive (Positive) positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided. The patient received antibody treatment on 16-Apr-2021.
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test
Clinical narrative: tested positive for COVID; fever 102; chills; body aches; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of COVID-19 (tested positive for COVID), PYREXIA (fever 102), CHILLS (chills) and MYALGIA (body aches) in a 55-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Apr-2021, the patient experienced COVID-19 (tested positive for COVID), PYREXIA (fever 102), CHILLS (chills) and MYALGIA (body aches). At the time of the report, COVID-19 (tested positive for COVID), PYREXIA (fever 102), CHILLS (chills) and MYALGIA (body aches) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 12-Apr-2021, Body temperature: 102 (High) 102. On 12-Apr-2021, SARS-CoV-2 test: positive (Positive) positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided. The patient received antibody treatment on 16-Apr-2021.
Age: 19.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: One patient was given the Moderna COVID-19 Vaccination after the vial was punctured for more than 12 hours.; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (One patient was given the Moderna COVID-19 Vaccination after the vial was punctured for more than 12 hours.) in a 19-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 28-May-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-May-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (One patient was given the Moderna COVID-19 Vaccination after the vial was punctured for more than 12 hours.). On 28-May-2021, EXPIRED PRODUCT ADMINISTERED (One patient was given the Moderna COVID-19 Vaccination after the vial was punctured for more than 12 hours.) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product information was not provided.  Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 23-Jul-2021: Non Significant Follow-up added
Sex: M
Vaccine: COVID19
Symptoms: Peripheral swelling
Clinical narrative: Underarm swelled up; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Underarm swelled up) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 26-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PERIPHERAL SWELLING (Underarm swelled up). At the time of the report, PERIPHERAL SWELLING (Underarm swelled up) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product information was not provided. Treatment information was not provided.
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Myalgia, Nasopharyngitis
Clinical narrative: Very cold; Feels achy; Tired; This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (Very cold), MYALGIA (Feels achy) and FATIGUE (Tired) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history provided.     On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On an unknown date, the patient experienced NASOPHARYNGITIS (Very cold), MYALGIA (Feels achy) and FATIGUE (Tired). At the time of the report, NASOPHARYNGITIS (Very cold), MYALGIA (Feels achy) and FATIGUE (Tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product information was not provided. Treatment information was not provided.
Sex: U
Vaccine: COVID19
Symptoms: Nasal congestion, Oropharyngeal pain
Clinical narrative: Had a sore throat; Suffing nose; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (Had a sore throat) and NASAL CONGESTION (Suffing nose) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced OROPHARYNGEAL PAIN (Had a sore throat) and NASAL CONGESTION (Suffing nose). At the time of the report, OROPHARYNGEAL PAIN (Had a sore throat) and NASAL CONGESTION (Suffing nose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product information was not provided. Treatment information was not provided.
Sex: U
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: Arm is pretty sore; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Arm is pretty sore) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MYALGIA (Arm is pretty sore). At the time of the report, MYALGIA (Arm is pretty sore) outcome was unknown.            Concomitant Medications were not provided by the reporter. Treatment Medications were not provided by the reporter.   Reporter did not allow further contact
Sex: U
Vaccine: COVID19
Symptoms: Injection site haemorrhage, Injection site rash
Clinical narrative: injection site has a round circle and is bleeding; injection site has a round circle and is bleeding; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE HAEMORRHAGE (injection site has a round circle and is bleeding) and INJECTION SITE RASH (injection site has a round circle and is bleeding) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INJECTION SITE HAEMORRHAGE (injection site has a round circle and is bleeding) and INJECTION SITE RASH (injection site has a round circle and is bleeding). At the time of the report, INJECTION SITE HAEMORRHAGE (injection site has a round circle and is bleeding) and INJECTION SITE RASH (injection site has a round circle and is bleeding) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Reporter did not allow further contact
Age: 85.0
Sex: U
Vaccine: COVID19
Symptoms: Breast swelling
Clinical narrative: Swelling in my rt breast; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of BREAST SWELLING (Swelling in my rt breast) in an 85-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced BREAST SWELLING (Swelling in my rt breast). At the time of the report, BREAST SWELLING (Swelling in my rt breast) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No concomitant medications were provided No treatment medications were provided   Reporter did not allow further contact
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Ear pain, Mobility decreased, Myalgia, Pain
Clinical narrative: Right sided body px from waist down; My flexability is bad; Fever; Tooth ache; Ear ache; Right sided body aches and px; Myalgia; Legs are especially painful; Achy joints from the hips down; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Right sided body px from waist down), PAIN IN EXTREMITY (Legs are especially painful), PAIN (Right sided body aches and px), MYALGIA (Myalgia) and TOOTHACHE (Tooth ache) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 024M20A and 041620A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Myocardial infarction (Chronic or longstanding health condition: MI) since 11-Jan-2013. Concomitant products included EICOSAPENTAENOIC ACID ETHYL ESTER (VASCEPA) from 11-Jan-2013 to an unknown date and ATORVASTATIN from 11-Jan-2013 to an unknown date for Cholesterol, ASA from 11-Jan-2013 to an unknown date, CLOPIDOGREL from 11-Jan-2013 to an unknown date and OLMESARTAN MEDOXOMIL (OLMERTAN) from 11-Jan-2013 to an unknown date for Myocardial infarction, TAMSULOSIN HCL.   On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021 at 4:30 PM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 19-Feb-2021, the patient experienced PAIN IN EXTREMITY (Legs are especially painful), MYALGIA (Myalgia) and ARTHRALGIA (Achy joints from the hips down). On 19-Feb-2021 at 9:00 PM, the patient experienced PAIN (Right sided body aches and px), TOOTHACHE (Tooth ache), EAR PAIN (Ear ache) and PYREXIA (Fever). On an unknown date, the patient experienced PAIN IN EXTREMITY (Right sided body px from waist down) and MOBILITY DECREASED (My flexability is bad). At the time of the report, PAIN IN EXTREMITY (Right sided body px from waist down) had resolved with sequelae, PAIN IN EXTREMITY (Legs are especially painful), MOBILITY DECREASED (My flexability is bad) and ARTHRALGIA (Achy joints from the hips down) outcome was unknown and PAIN (Right sided body aches and px), MYALGIA (Myalgia), TOOTHACHE (Tooth ache), EAR PAIN (Ear ache) and PYREXIA (Fever) had not resolved.            No concomitant medications were provided No treatment medications were provided   Most recent FOLLOW-UP information incorporated above includes: On 28-May-2021: Follow up was received on 28-May-2021  Non significant case included no new information. On 10-Jun-2021: Follow up-2 was received on 10-Jun-2021. Patient gender, height, weight, ethinicity, race and current condition were updated. Moderna vaccine dose 1 information and concomitant medication details were provided. Details of new events were updated.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Pyrexia, Toothache
Clinical narrative: Right sided body px from waist down; My flexability is bad; Fever; Tooth ache; Ear ache; Right sided body aches and px; Myalgia; Legs are especially painful; Achy joints from the hips down; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Right sided body px from waist down), PAIN IN EXTREMITY (Legs are especially painful), PAIN (Right sided body aches and px), MYALGIA (Myalgia) and TOOTHACHE (Tooth ache) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 024M20A and 041620A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Myocardial infarction (Chronic or longstanding health condition: MI) since 11-Jan-2013. Concomitant products included EICOSAPENTAENOIC ACID ETHYL ESTER (VASCEPA) from 11-Jan-2013 to an unknown date and ATORVASTATIN from 11-Jan-2013 to an unknown date for Cholesterol, ASA from 11-Jan-2013 to an unknown date, CLOPIDOGREL from 11-Jan-2013 to an unknown date and OLMESARTAN MEDOXOMIL (OLMERTAN) from 11-Jan-2013 to an unknown date for Myocardial infarction, TAMSULOSIN HCL.   On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021 at 4:30 PM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 19-Feb-2021, the patient experienced PAIN IN EXTREMITY (Legs are especially painful), MYALGIA (Myalgia) and ARTHRALGIA (Achy joints from the hips down). On 19-Feb-2021 at 9:00 PM, the patient experienced PAIN (Right sided body aches and px), TOOTHACHE (Tooth ache), EAR PAIN (Ear ache) and PYREXIA (Fever). On an unknown date, the patient experienced PAIN IN EXTREMITY (Right sided body px from waist down) and MOBILITY DECREASED (My flexability is bad). At the time of the report, PAIN IN EXTREMITY (Right sided body px from waist down) had resolved with sequelae, PAIN IN EXTREMITY (Legs are especially painful), MOBILITY DECREASED (My flexability is bad) and ARTHRALGIA (Achy joints from the hips down) outcome was unknown and PAIN (Right sided body aches and px), MYALGIA (Myalgia), TOOTHACHE (Tooth ache), EAR PAIN (Ear ache) and PYREXIA (Fever) had not resolved.            No concomitant medications were provided No treatment medications were provided   Most recent FOLLOW-UP information incorporated above includes: On 28-May-2021: Follow up was received on 28-May-2021  Non significant case included no new information. On 10-Jun-2021: Follow up-2 was received on 10-Jun-2021. Patient gender, height, weight, ethinicity, race and current condition were updated. Moderna vaccine dose 1 information and concomitant medication details were provided. Details of new events were updated.
Sex: U
Vaccine: COVID19
Symptoms: Vaccination site swelling
Clinical narrative: Area where the shot is puffy; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (Area where the shot is puffy) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE SWELLING (Area where the shot is puffy). At the time of the report, VACCINATION SITE SWELLING (Area where the shot is puffy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter. Treatment information was not provided.
Sex: U
Vaccine: COVID19
Symptoms: Pre-existing condition improved, Therapeutic response unexpected
Clinical narrative: my sprained ankle is so much better; my sprained ankle is so much better; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of THERAPEUTIC RESPONSE UNEXPECTED (my sprained ankle is so much better) and PRE-EXISTING CONDITION IMPROVED (my sprained ankle is so much better) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced THERAPEUTIC RESPONSE UNEXPECTED (my sprained ankle is so much better) and PRE-EXISTING CONDITION IMPROVED (my sprained ankle is so much better). At the time of the report, THERAPEUTIC RESPONSE UNEXPECTED (my sprained ankle is so much better) and PRE-EXISTING CONDITION IMPROVED (my sprained ankle is so much better) outcome was unknown.            The patient reported that after her second dose of mRNA-1273 her arthritis has gotten much better Concomitant medication was not reported. Treatment information was not provided.
Age: 27.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Interchange of vaccine products
Clinical narrative: Patient received the Pfizer COVID-19 vaccine as their second dose; This spontaneous case was reported by a pharmacist and describes the occurrence of INTERCHANGE OF VACCINE PRODUCTS (Patient received the Pfizer COVID-19 vaccine as their second dose) in a 27-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) for COVID-19 vaccination.    No Medical History information was reported.   On 02-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-May-2021, the patient started TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) (Intramuscular) 1 dosage form. On 30-May-2021, the patient experienced INTERCHANGE OF VACCINE PRODUCTS (Patient received the Pfizer COVID-19 vaccine as their second dose). On 30-May-2021, INTERCHANGE OF VACCINE PRODUCTS (Patient received the Pfizer COVID-19 vaccine as their second dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The patient has not reported any side effects or symptoms after the first or second vaccination. The pharmacist asked whether the patient would require an additional vaccine dose of the Moderna COVID-19 vaccine to complete the series for the patient after being given one dose of the Moderna COVID-19 vaccine and one dose of the Pfizer COVID-19 vaccine.
Sex: U
Vaccine: COVID19
Symptoms: Swollen tongue
Clinical narrative: uour tongue swell up after ghe shot; This spontaneous case was reported by a consumer and describes the occurrence of SWOLLEN TONGUE (uour tongue swell up after ghe shot) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced SWOLLEN TONGUE (uour tongue swell up after ghe shot). At the time of the report, SWOLLEN TONGUE (uour tongue swell up after ghe shot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication provided.  No treatment information provided.
Sex: M
Vaccine: COVID19
Symptoms: Epistaxis
Clinical narrative: Bloody nose/Having trouble stopping bleeding; This spontaneous case was reported by a consumer and describes the occurrence of EPISTAXIS (Bloody nose/Having trouble stopping bleeding) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced EPISTAXIS (Bloody nose/Having trouble stopping bleeding). At the time of the report, EPISTAXIS (Bloody nose/Having trouble stopping bleeding) outcome was unknown.            Concomitant product information was not provided. Treatment information was not provided Action taken with mRNA-1273 in response to the events was not applicable.
Sex: U
Vaccine: COVID19
Symptoms: Illness, Pyrexia
Clinical narrative: Sick; Friends who are the same age got the shot and it made them very sick up to 103 fever; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Sick) and PYREXIA (Friends who are the same age got the shot and it made them very sick up to 103 fever) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ILLNESS (Sick) and PYREXIA (Friends who are the same age got the shot and it made them very sick up to 103 fever). At the time of the report, ILLNESS (Sick) and PYREXIA (Friends who are the same age got the shot and it made them very sick up to 103 fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product information was not provided. Treatment information was not provided.
Age: 27.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of vaccination site pain (arm pain) in a 27-year-old male patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 047B21A) for COVID-19 immunization. No medical history reported. On Apr 30, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On Apr 30, 2021, patient experienced vaccination site pain (arm pain). The patient treated with paracetamol (oral) for pain in arm, at a dose of 500 mg once. On May 1, 2021, vaccination site pain (arm pain) resolved. The action taken with mRNA-1273 (Moderna COVID-19 vaccine): unknown. The reporter did not provide any causality assessments or concomitant medication.
Sex: U
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: side effects; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (side effects) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (side effects). At the time of the report, VACCINATION COMPLICATION (side effects) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication provided by the reporter no treatment information reported by the reporter